APO Research
Talk to an analyst

APO RESEARCH · REPORT

Placenta Growth Factor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Placenta Growth Factor Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchPlacenta Growth Factor Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Placenta Growth Factor Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Placenta Growth Factor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Placenta Growth Factor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Placenta Growth Factor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Placenta Growth Factor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Placenta Growth Factor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Placenta Growth Factor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Placenta Growth Factor market include Alteogen Inc., Clearside BioMedical, Inc., Formycon AG, Regeneron Pharmaceuticals Inc, ThromboGenics NV and Chengdu Kanghong Pharmaceuticals Group Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Placenta Growth Factor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Placenta Growth Factor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Placenta Growth Factor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Placenta Growth Factor market size, projected growth trends, production technologies, key applications, and end-use industries.

Placenta Growth Factor Segment by Company

Alteogen Inc.

Clearside BioMedical, Inc.

Formycon AG

Regeneron Pharmaceuticals Inc

ThromboGenics NV

Chengdu Kanghong Pharmaceuticals Group Co Ltd

Placenta Growth Factor Segment by Type

SL-186

SL-188

Aflibercept

Aflibercept Biosimilar

Others

Placenta Growth Factor Segment by Application

Neovascular Glaucoma

Myopia

Branch Retinal Vein Occlusion

Others

Placenta Growth Factor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Placenta Growth Factor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Placenta Growth Factor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Placenta Growth Factor significant trends, drivers, influence factors in global and regions.

6. To analyze Placenta Growth Factor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Placenta Growth Factor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Placenta Growth Factor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Placenta Growth Factor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Placenta Growth Factor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Placenta Growth Factor industry.

Chapter 3: Detailed analysis of Placenta Growth Factor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Placenta Growth Factor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Placenta Growth Factor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Placenta Growth Factor Industry Trends Table 2. Placenta Growth Factor Industry Drivers Table 3. Placenta Growth Factor Industry Opportunities and Challenges Table 4. Placenta Growth Factor Industry Restraints Table 5. Global Placenta Growth Factor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Placenta Growth Factor Revenue Share by Company (2021-2026) Table 7. Global Placenta Growth Factor Sales Volume by Company (k units) & (2021-2026) Table 8. Global Placenta Growth Factor Sales Volume Share by Company (2021-2026) Table 9. Global Placenta Growth Factor Average Price (US$/unit) of Company (2021-2026) Table 10. Global Placenta Growth Factor Company Ranking, (2024-2026) & (USD Million) Table 11. Global Placenta Growth Factor Key Company Manufacturing Base & Headquarters Table 12. Global Placenta Growth Factor Company, Product Type & Application Table 13. Global Placenta Growth Factor Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Placenta Growth Factor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of SL-186 Table 18. Significant Companies of SL-188 Table 19. Significant Companies of Aflibercept Table 20. Significant Companies of Aflibercept Biosimilar Table 21. Significant Companies of Others Table 22. Global Placenta Growth Factor Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Placenta Growth Factor Sales Volume by Type (2021-2026) & (k units) Table 24. Global Placenta Growth Factor Sales Volume by Type (2027-2032) & (k units) Table 25. Global Placenta Growth Factor Sales Volume Share by Type (2021-2026) Table 26. Global Placenta Growth Factor Sales Volume Share by Type (2027-2032) Table 27. Global Placenta Growth Factor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Placenta Growth Factor Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Placenta Growth Factor Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Placenta Growth Factor Sales Value Share by Type (2021-2026) Table 31. Global Placenta Growth Factor Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Neovascular Glaucoma Table 33. Significant Companies of Myopia Table 34. Significant Companies of Branch Retinal Vein Occlusion Table 35. Significant Companies of Others Table 36. Global Placenta Growth Factor Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Placenta Growth Factor Sales Volume by Application (2021-2026) & (k units) Table 38. Global Placenta Growth Factor Sales Volume by Application (2027-2032) & (k units) Table 39. Global Placenta Growth Factor Sales Volume Share by Application (2021-2026) Table 40. Global Placenta Growth Factor Sales Volume Share by Application (2027-2032) Table 41. Global Placenta Growth Factor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Placenta Growth Factor Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Placenta Growth Factor Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Placenta Growth Factor Sales Value Share by Application (2021-2026) Table 45. Global Placenta Growth Factor Sales Value Share by Application (2027-2032) Table 46. Global Placenta Growth Factor Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Placenta Growth Factor Sales by Region (2021-2026) & (k units) Table 48. Global Placenta Growth Factor Sales Market Share by Region (2021-2026) Table 49. Global Placenta Growth Factor Sales by Region (2027-2032) & (k units) Table 50. Global Placenta Growth Factor Sales Market Share by Region (2027-2032) Table 51. Global Placenta Growth Factor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Placenta Growth Factor Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Placenta Growth Factor Sales Value Share by Region (2021-2026) Table 54. Global Placenta Growth Factor Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Placenta Growth Factor Sales Value Share by Region (2027-2032) Table 56. Global Placenta Growth Factor Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global Placenta Growth Factor Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global Placenta Growth Factor Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Placenta Growth Factor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Placenta Growth Factor Sales by Country (2021-2026) & (k units) Table 61. Global Placenta Growth Factor Sales Market Share by Country (2021-2026) Table 62. Global Placenta Growth Factor Sales by Country (2027-2032) & (k units) Table 63. Global Placenta Growth Factor Sales Market Share by Country (2027-2032) Table 64. Global Placenta Growth Factor Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Placenta Growth Factor Sales Value Market Share by Country (2021-2026) Table 66. Global Placenta Growth Factor Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Placenta Growth Factor Sales Value Market Share by Country (2027-2032) Table 68. Alteogen Inc. Company Information Table 69. Alteogen Inc. Business Overview Table 70. Alteogen Inc. Placenta Growth Factor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Alteogen Inc. Placenta Growth Factor Product Portfolio Table 72. Alteogen Inc. Recent Development Table 73. Clearside BioMedical, Inc. Company Information Table 74. Clearside BioMedical, Inc. Business Overview Table 75. Clearside BioMedical, Inc. Placenta Growth Factor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Clearside BioMedical, Inc. Placenta Growth Factor Product Portfolio Table 77. Clearside BioMedical, Inc. Recent Development Table 78. Formycon AG Company Information Table 79. Formycon AG Business Overview Table 80. Formycon AG Placenta Growth Factor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Formycon AG Placenta Growth Factor Product Portfolio Table 82. Formycon AG Recent Development Table 83. Regeneron Pharmaceuticals Inc Company Information Table 84. Regeneron Pharmaceuticals Inc Business Overview Table 85. Regeneron Pharmaceuticals Inc Placenta Growth Factor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Regeneron Pharmaceuticals Inc Placenta Growth Factor Product Portfolio Table 87. Regeneron Pharmaceuticals Inc Recent Development Table 88. ThromboGenics NV Company Information Table 89. ThromboGenics NV Business Overview Table 90. ThromboGenics NV Placenta Growth Factor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. ThromboGenics NV Placenta Growth Factor Product Portfolio Table 92. ThromboGenics NV Recent Development Table 93. Chengdu Kanghong Pharmaceuticals Group Co Ltd Company Information Table 94. Chengdu Kanghong Pharmaceuticals Group Co Ltd Business Overview Table 95. Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Product Portfolio Table 97. Chengdu Kanghong Pharmaceuticals Group Co Ltd Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Placenta Growth Factor Distributors List Table 101. Placenta Growth Factor Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Placenta Growth Factor Product Image Figure 2. Global Placenta Growth Factor Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Placenta Growth Factor Sales Value (2021-2032) & (US$ Million) Figure 4. Global Placenta Growth Factor Sales (2021-2032) & (k units) Figure 5. Global Placenta Growth Factor Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Placenta Growth Factor Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. SL-186 Image Figure 10. SL-188 Image Figure 11. Aflibercept Image Figure 12. Aflibercept Biosimilar Image Figure 13. Others Image Figure 14. Global Placenta Growth Factor Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Placenta Growth Factor Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Placenta Growth Factor Sales Volume Share by Type (2021-2032) Figure 17. Global Placenta Growth Factor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Placenta Growth Factor Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Placenta Growth Factor Sales Value Share by Type (2021-2032) Figure 20. Neovascular Glaucoma Image Figure 21. Myopia Image Figure 22. Branch Retinal Vein Occlusion Image Figure 23. Others Image Figure 24. Global Placenta Growth Factor Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Placenta Growth Factor Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Placenta Growth Factor Sales Volume Share by Application (2021-2032) Figure 27. Global Placenta Growth Factor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Placenta Growth Factor Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Placenta Growth Factor Sales Value Share by Application (2021-2032) Figure 30. Global Placenta Growth Factor Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Placenta Growth Factor Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Placenta Growth Factor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Placenta Growth Factor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Placenta Growth Factor Sales Value (2021-2032) & (US$ Million) Figure 35. North America Placenta Growth Factor Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Placenta Growth Factor Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Placenta Growth Factor Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Placenta Growth Factor Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Placenta Growth Factor Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Placenta Growth Factor Sales Value (2021-2032) & (US$ Million) Figure 41. South America Placenta Growth Factor Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Placenta Growth Factor Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Placenta Growth Factor Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Placenta Growth Factor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Placenta Growth Factor Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Placenta Growth Factor Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • SL-186
  • SL-188
  • Aflibercept
  • Aflibercept Biosimilar
  • Others
Applications
  • Neovascular Glaucoma
  • Myopia
  • Branch Retinal Vein Occlusion
  • Others
Companies covered
  • Alteogen Inc.
  • Clearside BioMedical, Inc.
  • Formycon AG
  • Regeneron Pharmaceuticals Inc
  • ThromboGenics NV
  • Chengdu Kanghong Pharmaceuticals Group Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Placenta Growth Factor Sales Value (2021-2032)
  4. 1.2.2 Global Placenta Growth Factor Sales Volume (2021-2032)
  5. 1.2.3 Global Placenta Growth Factor Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Placenta Growth Factor Market Dynamics
  1. 2.1 Placenta Growth Factor Industry Trends
  2. 2.2 Placenta Growth Factor Industry Drivers
  3. 2.3 Placenta Growth Factor Industry Opportunities and Challenges
  4. 2.4 Placenta Growth Factor Industry Restraints
3 Placenta Growth Factor Market by Company
  1. 3.1 Global Placenta Growth Factor Company Revenue Ranking in 2025
  2. 3.2 Global Placenta Growth Factor Revenue by Company (2021-2026)
  3. 3.3 Global Placenta Growth Factor Sales Volume by Company (2021-2026)
  4. 3.4 Global Placenta Growth Factor Average Price by Company (2021-2026)
  5. 3.5 Global Placenta Growth Factor Company Ranking (2024-2026)
  6. 3.6 Global Placenta Growth Factor Company Manufacturing Base and Headquarters
  7. 3.7 Global Placenta Growth Factor Company Product Type and Application
  8. 3.8 Global Placenta Growth Factor Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Placenta Growth Factor Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Placenta Growth Factor Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Placenta Growth Factor Market by Type
  1. 4.1 Placenta Growth Factor Type Introduction
  2. 4.1.1 SL-186
  3. 4.1.2 SL-188
  4. 4.1.3 Aflibercept
  5. 4.1.4 Aflibercept Biosimilar
  6. 4.1.5 Others
  7. 4.2 Global Placenta Growth Factor Sales Volume by Type
  8. 4.2.1 Global Placenta Growth Factor Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Placenta Growth Factor Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Placenta Growth Factor Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Placenta Growth Factor Sales Value by Type
  12. 4.3.1 Global Placenta Growth Factor Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Placenta Growth Factor Sales Value by Type (2021-2032)
  14. 4.3.3 Global Placenta Growth Factor Sales Value Share by Type (2021-2032)
5 Placenta Growth Factor Market by Application
  1. 5.1 Placenta Growth Factor Application Introduction
  2. 5.1.1 Neovascular Glaucoma
  3. 5.1.2 Myopia
  4. 5.1.3 Branch Retinal Vein Occlusion
  5. 5.1.4 Others
  6. 5.2 Global Placenta Growth Factor Sales Volume by Application
  7. 5.2.1 Global Placenta Growth Factor Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Placenta Growth Factor Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Placenta Growth Factor Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Placenta Growth Factor Sales Value by Application
  11. 5.3.1 Global Placenta Growth Factor Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Placenta Growth Factor Sales Value by Application (2021-2032)
  13. 5.3.3 Global Placenta Growth Factor Sales Value Share by Application (2021-2032)
6 Placenta Growth Factor Regional Sales and Value Analysis
  1. 6.1 Global Placenta Growth Factor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Placenta Growth Factor Sales by Region (2021-2032)
  3. 6.2.1 Global Placenta Growth Factor Sales by Region: 2021-2026
  4. 6.2.2 Global Placenta Growth Factor Sales by Region (2027-2032)
  5. 6.3 Global Placenta Growth Factor Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Placenta Growth Factor Sales Value by Region (2021-2032)
  7. 6.4.1 Global Placenta Growth Factor Sales Value by Region: 2021-2026
  8. 6.4.2 Global Placenta Growth Factor Sales Value by Region (2027-2032)
  9. 6.5 Global Placenta Growth Factor Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Placenta Growth Factor Sales Value (2021-2032)
  12. 6.6.2 North America Placenta Growth Factor Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Placenta Growth Factor Sales Value (2021-2032)
  15. 6.7.2 Europe Placenta Growth Factor Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Placenta Growth Factor Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Placenta Growth Factor Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Placenta Growth Factor Sales Value (2021-2032)
  21. 6.9.2 South America Placenta Growth Factor Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Placenta Growth Factor Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Placenta Growth Factor Sales Value Share by Country, 2025 VS 2032
7 Placenta Growth Factor Country-level Sales and Value Analysis
  1. 7.1 Global Placenta Growth Factor Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Placenta Growth Factor Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Placenta Growth Factor Sales by Country (2021-2032)
  4. 7.3.1 Global Placenta Growth Factor Sales by Country (2021-2026)
  5. 7.3.2 Global Placenta Growth Factor Sales by Country (2027-2032)
  6. 7.4 Global Placenta Growth Factor Sales Value by Country (2021-2032)
  7. 7.4.1 Global Placenta Growth Factor Sales Value by Country (2021-2026)
  8. 7.4.2 Global Placenta Growth Factor Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Placenta Growth Factor Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Placenta Growth Factor Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Placenta Growth Factor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alteogen Inc.
  2. 8.1.1 Alteogen Inc. Company Information
  3. 8.1.2 Alteogen Inc. Business Overview
  4. 8.1.3 Alteogen Inc. Placenta Growth Factor Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alteogen Inc. Placenta Growth Factor Product Portfolio
  6. 8.1.5 Alteogen Inc. Recent Developments
  7. 8.2 Clearside BioMedical, Inc.
  8. 8.2.1 Clearside BioMedical, Inc. Company Information
  9. 8.2.2 Clearside BioMedical, Inc. Business Overview
  10. 8.2.3 Clearside BioMedical, Inc. Placenta Growth Factor Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Clearside BioMedical, Inc. Placenta Growth Factor Product Portfolio
  12. 8.2.5 Clearside BioMedical, Inc. Recent Developments
  13. 8.3 Formycon AG
  14. 8.3.1 Formycon AG Company Information
  15. 8.3.2 Formycon AG Business Overview
  16. 8.3.3 Formycon AG Placenta Growth Factor Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Formycon AG Placenta Growth Factor Product Portfolio
  18. 8.3.5 Formycon AG Recent Developments
  19. 8.4 Regeneron Pharmaceuticals Inc
  20. 8.4.1 Regeneron Pharmaceuticals Inc Company Information
  21. 8.4.2 Regeneron Pharmaceuticals Inc Business Overview
  22. 8.4.3 Regeneron Pharmaceuticals Inc Placenta Growth Factor Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Regeneron Pharmaceuticals Inc Placenta Growth Factor Product Portfolio
  24. 8.4.5 Regeneron Pharmaceuticals Inc Recent Developments
  25. 8.5 ThromboGenics NV
  26. 8.5.1 ThromboGenics NV Company Information
  27. 8.5.2 ThromboGenics NV Business Overview
  28. 8.5.3 ThromboGenics NV Placenta Growth Factor Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ThromboGenics NV Placenta Growth Factor Product Portfolio
  30. 8.5.5 ThromboGenics NV Recent Developments
  31. 8.6 Chengdu Kanghong Pharmaceuticals Group Co Ltd
  32. 8.6.1 Chengdu Kanghong Pharmaceuticals Group Co Ltd Company Information
  33. 8.6.2 Chengdu Kanghong Pharmaceuticals Group Co Ltd Business Overview
  34. 8.6.3 Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chengdu Kanghong Pharmaceuticals Group Co Ltd Placenta Growth Factor Product Portfolio
  36. 8.6.5 Chengdu Kanghong Pharmaceuticals Group Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Placenta Growth Factor Value Chain Analysis
  2. 9.1.1 Placenta Growth Factor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Placenta Growth Factor Sales Mode & Process
  6. 9.2 Placenta Growth Factor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Placenta Growth Factor Distributors
  9. 9.2.3 Placenta Growth Factor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst